Myocardial Infarction Is Estimated To Witness High Growth Owing To Rising Prevalence Of Cardiovascular Diseases
Myocardial infarction, commonly known as heart attack,
occurs when a section of the heart muscle does not receive enough blood supply
and dies. The typical symptoms include chest pain, shortness of breath, nausea,
vomiting, and profuse sweating. Increasing prevalence of risk factors such as
obesity, smoking, diabetes, high cholesterol, and high blood pressure has
fueled the incidence of cardiovascular diseases such as myocardial infarction.
The demand for innovative diagnostic devices, medications, and treatment
procedures is escalating to manage myocardial infarction.
The
global Myocardial Infarction Market is
estimated to be valued at Us$ 2347.22
Bn in 2024 and is expected to
exhibit a CAGR Of 22% over the
forecast period 2024-2031, as
highlighted in a new report published by Coherent Market Insights.
Market Opportunity:
The rising prevalence of cardiovascular diseases represented a major
opportunity in the myocardial infarction market. According to the World Health
Organization, cardiovascular diseases are estimated to be the leading cause of
deaths globally, accounting for over 17.9 million lives lost each year. Over
75% of these deaths occur in low- and middle-income countries. The growing
burden of cardiovascular conditions in developing nations due to lifestyle
changes and expanding geriatric population base is expected to boost the demand
for myocardial infarction management and treatment in these regions. Efforts
should be directed towards spreading awareness regarding healthy lifestyle,
risk factors, and early detection of cardiovascular ailments to curb this
rising prevalence and associated healthcare costs.
Porter's Analysis
Threat of new entrants: Low as it requires high capital investment and strict
regulatory approvals to enter this market.
Bargaining power of buyers: Moderate as major key players AT&T Inc.,
Verizon Communications Inc., etc operating. Customers can switch easily between
brands.
Bargaining power of suppliers: Moderate as market dominated by few key players
who source from select suppliers globally.
Threat of new substitutes: Low as no close substitute present for core
offerings.
Competitive rivalry: High rivalry exists due to presence of global key players
offering similar services.
SWOT Analysis
Strength: Established global distribution network and brand recognition for key
players. Advanced technologies available for effective treatment.
Weakness: High cost of treatment and devices. Lack of infrastructure and
awareness in developing nations.
Opportunity: Growing geriatric population and lifestyle diseases prevalence
increases demand. Emerging markets offer scope with increasing disposable
incomes.
Threats: Stringent regulations. Reimbursement issues and economic slowdowns
impact market.
Key Takeaways
The Global Myocardial Infarction Market Demand is
expected to witness high growth at a CAGR of 22% during the forecast period of
2024 to 2031. The market size is projected to grow from US$ 2347.22 Bn in 2024
to US$ 12143 Bn by 2031.
Regional analysis for myocardial infarction market comprises fastest growing
markets in Asia Pacific region majorly in India and China. Factors such as
growing geriatric population, increasing lifestyle diseases, rising healthcare
spends drive the demand.
Key players operating in the myocardial infarction market are AT&T Inc.,
Verizon Communications Inc., NTT Communications Corporation, China Telecom
Corporation Limited, Deutsche Telekom AG, British Telecommunications plc (BT),
Orange S.A., Telefonica S.A., Sprint Corporation (now part of T-Mobile),
CenturyLink (now rebranded as Lumen Technologies), Vodafone Group plc, SoftBank
Group Corp., Level 3 Communications, Telstra Corporation Limited, Tata
Communications Limited.
Get more insights on this topic :
Comments
Post a Comment